| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |